Infantile epileptic spasms syndrome: a cohort study of 88 children

Li-Hong Ren1, Jing Zhang1, Si-Xiu Li1

  • 1Department of Pediatric Neurology, School of Medicine, Chengdu Women's and Children's Central Hospital, University of Electronic Science and Technology of China, No. 1617, Riyue Aveneue, Chengdu, 611731, China.

PubMed

Insights

Gender and metabolic abnormalities are key risk factors for non-etiology-specific infantile spasms (IS). Etiology also impacts symptom relief after treatment for IS.

Area of Science:

  • Pediatric Neurology
  • Clinical Research
  • Medical Diagnostics

Background:

  • Infantile spasms (IS) present diagnostic and treatment challenges.
  • Understanding risk factors for non-etiology-specific IS is crucial.
  • Identifying predictors of treatment response is essential for improved outcomes.

Purpose of the Study:

  • To investigate risk factors for non-etiology-specific infantile spasms (IS).
  • To analyze factors associated with unrelieved clinical symptoms after IS treatment.

Main Methods:

  • Retrospective analysis of 88 children with IS (March 2018-December 2021).
  • Patients categorized into etiology-specific vs. non-etiology-specific groups.
  • Patients also grouped by remission vs. nonremission status post-treatment.
  • Logistic regression analysis identified risk factors for non-etiology-specific IS.

Main Results:

  • Significant differences between etiology-specific and non-etiology-specific groups included gender, family history, birth status, and metabolic abnormalities.
  • Gender and metabolic abnormalities identified as risk factors for non-etiology-specific IS.
  • Differences between remission and nonremission groups included family history, birth status, metabolic abnormalities, and brain MRI findings.
  • Etiology emerged as a significant risk factor for unrelieved IS symptoms post-treatment.

Conclusions:

  • Childhood infantile spasms without a clear etiology are linked to gender and metabolic abnormalities.
  • The underlying etiology of IS is a critical factor influencing symptom persistence after treatment.
Abstract